ATE98872T1 - Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie. - Google Patents

Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.

Info

Publication number
ATE98872T1
ATE98872T1 AT89311322T AT89311322T ATE98872T1 AT E98872 T1 ATE98872 T1 AT E98872T1 AT 89311322 T AT89311322 T AT 89311322T AT 89311322 T AT89311322 T AT 89311322T AT E98872 T1 ATE98872 T1 AT E98872T1
Authority
AT
Austria
Prior art keywords
antagonist
preventing
interleukin
reducing eosinophilia
reducing
Prior art date
Application number
AT89311322T
Other languages
English (en)
Inventor
Robert L Coffman
Donna M Rennick
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23016493&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE98872(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE98872T1 publication Critical patent/ATE98872T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Head (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pens And Brushes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
AT89311322T 1988-11-03 1989-11-01 Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie. ATE98872T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26690988A 1988-11-03 1988-11-03
EP89311322A EP0367596B1 (de) 1988-11-03 1989-11-01 Antagonist für Interleukin-5 zur Verhütung oder Verminderung von Eosinophilie

Publications (1)

Publication Number Publication Date
ATE98872T1 true ATE98872T1 (de) 1994-01-15

Family

ID=23016493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89311322T ATE98872T1 (de) 1988-11-03 1989-11-01 Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.

Country Status (17)

Country Link
EP (2) EP0441891A1 (de)
JP (1) JPH07563B2 (de)
KR (1) KR960002183B1 (de)
AT (1) ATE98872T1 (de)
AU (1) AU633034B2 (de)
CA (1) CA2002144C (de)
DE (1) DE68911653T2 (de)
DK (1) DK81691D0 (de)
ES (1) ES2062032T3 (de)
HK (1) HK186196A (de)
IE (1) IE63063B1 (de)
IL (1) IL92180A (de)
MY (1) MY107386A (de)
NZ (1) NZ243939A (de)
PH (1) PH26476A (de)
WO (1) WO1990004979A2 (de)
ZA (1) ZA898322B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL176393B1 (pl) * 1992-02-06 1999-05-31 Schering Corp Monoklonalne przeciwciało lub jego fragment, które wiąże się swoiście z ludzką interleukiną-5, hybrydoma wydzielająca monoklonalne przeciwciało, które wiąże się swoiście z ludzką interleukiną-5, polipeptyd izolowany DNA, zrekombinowany wektor komórki gospodarza, humanizowane monoklonalne przeciwciało oraz sposób wytwarzania polipeptydu, sposób wytwarzania humanizowanego monoklonalnego przeciwciała i kompozycja farmaceutyczna
AU6000894A (en) * 1993-02-01 1994-08-29 Michel Goldman Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
GB9412230D0 (en) * 1994-06-17 1994-08-10 Celltech Ltd Interleukin-5 specific recombiant antibodies
ES2277336T3 (es) * 1994-12-23 2007-07-01 Smithkline Beecham Corporation Antagonistas de il-5 recombinantes utiles en el tratamiento de enfermadades mediadas por il-5.
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US7399837B2 (en) 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5683892A (en) * 1994-12-23 1997-11-04 Smithkline Beecham Corporation DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
CN1326879C (zh) 2002-03-29 2007-07-18 先灵公司 人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物
EP2274009B1 (de) 2008-03-28 2013-11-13 GlaxoSmithKline LLC Behandlungsverfahren
EP3634467A4 (de) 2017-06-06 2021-07-28 GlaxoSmithKline LLC Biopharmazeutische zusammensetzungen und verfahren für pädiatrische patienten
CN109942706A (zh) * 2017-12-21 2019-06-28 三生国健药业（上海）股份有限公司 结合人il-5的单克隆抗体、其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666080B1 (de) * 1987-06-24 2004-01-21 Brigham & Women's Hospital Behandlung von Autoimmun-Erkrankungen durch orale Verabreichung von Autoantigenen

Also Published As

Publication number Publication date
CA2002144A1 (en) 1990-05-03
ZA898322B (en) 1990-11-28
WO1990004979A2 (en) 1990-05-17
WO1990004979A8 (en) 2005-06-16
DE68911653D1 (de) 1994-02-10
IE893525L (en) 1990-05-03
AU4644889A (en) 1990-05-28
JPH03505211A (ja) 1991-11-14
DK81691A (da) 1991-05-02
IE63063B1 (en) 1995-03-22
DK81691D0 (da) 1991-05-02
DE68911653T2 (de) 1994-04-07
MY107386A (en) 1995-11-30
NZ243939A (en) 1997-07-27
PH26476A (en) 1992-07-27
AU633034B2 (en) 1993-01-21
CA2002144C (en) 2000-03-28
JPH07563B2 (ja) 1995-01-11
HK186196A (en) 1996-10-11
EP0367596A1 (de) 1990-05-09
KR900701320A (ko) 1990-12-01
IL92180A0 (en) 1990-07-26
IL92180A (en) 1997-04-15
EP0367596B1 (de) 1993-12-22
ES2062032T3 (es) 1994-12-16
EP0441891A1 (de) 1991-08-21
KR960002183B1 (ko) 1996-02-13

Similar Documents

Publication Publication Date Title
ATE93144T1 (de) Methode zur verminderung der immunglobulin-ereaktion.
SG42954A1 (en) Antibody to human interleukin-6 receptor
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
ATE98872T1 (de) Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.
EP0216454A3 (en) Method of promoting animal growth
DE3684578D1 (de) Monoklonale antikoerper mit bindungsspezifitaet fuer menschliche prostatatumorantigene und methoden fuer ihre verwendung.
WO1991007986A8 (en) Method of treating septic shock
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
DE3890354T1 (de) Synthetisches polypeptid mit grippevirus-antigenreaktivitaet
FI875476A7 (fi) Hiiren hybridoma Lym-2 ja sillä tuotettu diagnostinen vasta-aine.
FI875475A7 (fi) Hiiren hybridoma Lym-1 ja sillä tuotettu diagnostinen vasta-aine.
CS495286A1 (en) Mouse lymhocytaric hybridom producing antibody against human choriogonadotropic hormone

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked